Biostar Pharmaceuticals, Inc.

BSPM · OTC
Analyze with AI
9/30/2017
6/30/2017
3/31/2017
12/31/2016
Assets
Cash & Equivalents$365$407$484$173
Short-Term Investments$0$0$0$0
Receivables$461$124$5,694$6,854
Inventory$171$167$165$167
Other Curr. Assets$0$193$0$171
Total Curr. Assets$997$891$6,343$7,365
Property Plant & Equip (Net)$5,846$5,820$5,817$5,867
Goodwill$0$0$0$0
Intangibles$5,381$5,421$5,485$5,607
Long-Term Investments$0$0$0$0
Tax Assets$2,625$2,575$2,535$2,515
Other NC Assets$26,579$26,071$21,313$21,148
Total NC Assets$40,431$39,886$35,150$35,137
Other Assets$0$0$0$0
Total Assets$41,427$40,777$41,493$42,502
Liabilities
Payables$2,686$2,731$2,528$2,842
Short-Term Debt$2,427$2,381$2,344$2,326
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$166$179$439$455
Total Curr. Liab.$5,279$5,291$5,311$5,623
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,279$5,291$5,311$5,623
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$3
Retained Earnings-$4,995-$4,870-$3,555-$2,541
AOCI$9,757$8,971$8,352$8,035
Other Equity$31,382$31,382$31,382$31,382
Total Equity$36,148$35,486$36,182$36,879
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$41,427$40,777$41,493$42,502
Net Debt$2,062$1,973$1,860$2,152
Biostar Pharmaceuticals, Inc. (BSPM) Financial Statements & Key Stats | AlphaPilot